Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Oct 13.
doi: 10.1097/MCA.0000000000001576. Online ahead of print.

Ticagrelor vs. clopidogrel in elderly patients following acute myocardial infarction: a multicenter international analysis

Ramzi Ibrahim  1 , Robert Seby  2 , Abdullah Shaik  3 , Malak Tahsin  4 , Mahmoud Abdelnabi  1 , Hoang Nhat Pham  5   6 , Nada Said  1 , Juan Farina  1 , Mayurkumar D Bhakta  1 , Eric H Yang  1 , John P Sweeney  1 , David Fortuin  1 , Chadi Ayoub  1 , Kwan Lee  1 , Reza Arsanjani  1
Affiliations

Ticagrelor vs. clopidogrel in elderly patients following acute myocardial infarction: a multicenter international analysis

Ramzi Ibrahim et al. Coron Artery Dis. .
No abstract available

PubMed Disclaimer

References

    1. Damluji AA, Forman DE, Wang TY, Chikwe J, Kunadian V, Rich MW, et al.; American Heart Association Cardiovascular Disease in Older Populations Committee of the Council on Clinical Cardiology and Council on Cardiovascular and Stroke Nursing; Council on Cardiovascular Radiology and Intervention; and Council on Lifestyle and Cardiometabolic Health. Management of acute coronary syndrome in the older adult population: a scientific statement from the American Heart Association. Circulation 2023; 147:e32–e62.
    1. Zhao X, Zhang J, Guo J, Wang J, Pan Y, Zhao X, et al. Comparison of safety and efficacy between clopidogrel and ticagrelor in elderly patients with acute coronary syndrome: a systematic review and meta-analysis. Front Pharmacol 2021; 12:743259.
    1. Cesarini D, Muraca I, Berteotti M, Gori AM, Sorrentino A, Bertelli A, et al. Pathophysiological and molecular basis of the side effects of ticagrelor: lessons from a case report. Int J Mol Sci 2023; 24:10844.
    1. Szummer K, Montez-Rath ME, Alfredsson J, Erlinge D, Lindahl B, Hofmann R, et al. Comparison between ticagrelor and clopidogrel in elderly patients with an acute coronary syndrome: insights from the Swedeheart Registry. Circulation 2020; 142:1700–1708.

LinkOut - more resources